Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ravi Jandhyala

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Pharmaceutical Medicine|January 7, 2022
Development and Validation of the Medical Affairs Pharmaceutical Physician Value (MAPPval) InstrumentRavi Jandhyala
Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS|January 10, 2012
Effectiveness of type A botulinum toxins for aesthetic indications and their relative economic impactRavi Jandhyala
Health and Quality of Life Outcomes|September 29, 2021
Design, validation and implementation of the post-acute (long) COVID-19 quality of life (PAC-19QoL) instrumentRavi Jandhyala
Drug Safety|September 26, 2019
Comment on: "Patient Registries: An Underused Resource for Medicines Evaluation: Operational Proposals for Increasing the Use of Patient Registries in Regulatory Assessments"Ravi Jandhyala
The Journal of Clinical and Aesthetic Dermatology|September 25, 2013
Impact of botulinum toxin a on the quality of life of subjects following treatment of facial linesRavi Jandhyala
Pharmaceutical Medicine|February 13, 2020
Influence of Pharmaceutical Company Engagement Activities on the Decision to Prescribe: A Pilot Survey of UK Rare Disease Medicine PrescribersRavi Jandhyala
Current Medical Research and Opinion|December 4, 2023
Guest editor foreword: real-world evidence and medical affairsRavi Jandhyala
Journal of Drugs in Dermatology : JDD|June 1, 2012
Relative potency of incobotulinumtoxinA vs onabotulinumtoxinA a meta-analysis of key evidenceRavi Jandhyala
Current Medical Research and Opinion|January 31, 2023
Development, validation and implementation of the medical affairs pharmaceutical physician work-related quality of life instrumentRavi Jandhyala
Frontiers in Pharmacology|March 11, 2022
Development of a Definition for Medical Affairs Using the Jandhyala Method for Observing Consensus Opinion Among Medical Affairs Pharmaceutical PhysiciansRavi Jandhyala
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Pharmaceutical Medicine|January 7, 2022
Development and Validation of the Medical Affairs Pharmaceutical Physician Value (MAPPval) InstrumentRavi Jandhyala
Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS|January 10, 2012
Effectiveness of type A botulinum toxins for aesthetic indications and their relative economic impactRavi Jandhyala
Health and Quality of Life Outcomes|September 29, 2021
Design, validation and implementation of the post-acute (long) COVID-19 quality of life (PAC-19QoL) instrumentRavi Jandhyala
Drug Safety|September 26, 2019
Comment on: "Patient Registries: An Underused Resource for Medicines Evaluation: Operational Proposals for Increasing the Use of Patient Registries in Regulatory Assessments"Ravi Jandhyala
The Journal of Clinical and Aesthetic Dermatology|September 25, 2013
Impact of botulinum toxin a on the quality of life of subjects following treatment of facial linesRavi Jandhyala
Pharmaceutical Medicine|February 13, 2020
Influence of Pharmaceutical Company Engagement Activities on the Decision to Prescribe: A Pilot Survey of UK Rare Disease Medicine PrescribersRavi Jandhyala
Current Medical Research and Opinion|December 4, 2023
Guest editor foreword: real-world evidence and medical affairsRavi Jandhyala
Journal of Drugs in Dermatology : JDD|June 1, 2012
Relative potency of incobotulinumtoxinA vs onabotulinumtoxinA a meta-analysis of key evidenceRavi Jandhyala
Current Medical Research and Opinion|January 31, 2023
Development, validation and implementation of the medical affairs pharmaceutical physician work-related quality of life instrumentRavi Jandhyala
Frontiers in Pharmacology|March 11, 2022
Development of a Definition for Medical Affairs Using the Jandhyala Method for Observing Consensus Opinion Among Medical Affairs Pharmaceutical PhysiciansRavi Jandhyala
Pageof 4